In an era where healthcare is shifting from reactive treatment to predictive intelligence, Dr. Latha Kiran Krishna Rajendran stands at the forefront of a medical revolution. Based in Bengaluru, she represents a dynamic new wave of physician-scientists who seamlessly merge high-volume clinical practice with cutting-edge artificial intelligence, transforming how healthcare is delivered and experienced.
As a General Practitioner and Consultant at Elova Hospitals, Dr. Latha manages a rigorous outpatient practice, treating over 10,000 patients annually. Her clinical expertise spans pediatric care, chronic disease management, obstetrics, and emergency stabilization. Yet, what truly sets her apart is her parallel life as an internationally acclaimed clinical researcher. With over 15 peer-reviewed publications, multiple books, and four Indian utility patents, her work in AI-driven oncology, predictive diagnostics, and tumor modeling is redefining the boundaries of precision medicine.
TheCconnects recently sat down with Dr. Latha Kiran to discuss her extraordinary journey from the frontlines of the COVID-19 pandemic to developing deep-learning frameworks for cancer prediction, and how she envisions the future of data-driven healthcare.
TheCconnects: Dr. Latha Kiran, it is a profound honor to speak with you. Your career sits at a fascinating intersection-managing high-volume public health on one hand, and pioneering highly specialized AI research on the other. Could you tell our readers about your professional journey and how you came to your current role at Elova Hospitals?
Dr. Latha Kiran Krishna Rajendran: Thank you so much for having me. My journey has been driven by a single, persistent question: How can we do this better? It began with my MBBS at the Vydehi Institute of Medical Sciences and Research Centre. Very early in my clinical exposure, I realized that while a physician’s intuition is vital, modern medicine desperately needs data-driven precision to scale effectively.
My real trial by fire occurred during my tenure as a Medical Officer at the Adugodi Urban Primary Health Centre. When the COVID-19 pandemic struck, I served on the frontlines, ultimately administering over 150,000 vaccinations and managing rapid diagnostic testing under immense pressure. Today, as a General Practitioner at Elova Hospitals, I consult 40 to 60 patients daily. This continuous exposure to raw, high-volume clinical reality is the engine of my research. Seeing the limitations of generalized treatments firsthand is what pushes me to develop predictive, AI-driven solutions, so we can transition from volume-driven models to precision-based care.
TheCconnects: Managing over 10,000 patients annually while publishing Q1 Scopus journal papers and securing utility patents is a monumental feat. Who or what has influenced your unique approach to medicine the most?
Dr. Latha Kiran Krishna Rajendran: My greatest influence has been the undeniable gap I see every day between what traditional medical imaging can do and what the human body is actually experiencing. For instance, in oncology, traditional imaging often falls short in detecting micro-metastases. Watching patients endure the toxicity of overgeneralized treatment protocols deeply affected me.
This realization shaped my core philosophy, which drives everything I do: The future of medicine lies not in treating diseases after they appear, but in predicting, preventing, and personalizing care before they progress. Furthermore, the global scientific community-particularly networks like IEEE and Sigma Xi-has profoundly influenced me by showing how computational science can unravel the most complex biological mysteries.
TheCconnects: You have spearheaded massive public health initiatives and complex clinical workflows. What are the biggest challenges you have faced in your career, and how did you overcome them?
Dr. Latha Kiran Krishna Rajendran: The most significant challenge was undoubtedly the sheer scale and chaos of the COVID-19 pandemic. Coordinating a public health response of that magnitude-managing public panic, ensuring vaccine distribution to 150,000 people, and maintaining daily patient care-was an immense logistical and emotional mountain. I overcame it by relying on strict protocol implementation, decisive team coordination, and absolute resilience.
On the research side, the primary challenge is bridging the “translational gap”-moving computational innovation from the laboratory into clinical application. Developing a machine-learning algorithm is one thing, but making it function seamlessly in a chaotic operating room is another entirely. We overcome this by constantly collaborating with surgical and clinical teams to ensure our AI models are practically applicable, not just theoretically sound.
TheCconnects: Your research in AI-driven oncology is highly cited and globally recognized. How do your specific technological solutions address the deepest pain points of modern cancer patients?
Dr. Latha Kiran Krishna Rajendran: A major pain point for cancer patients is the severe collateral damage caused by non-personalized therapies, such as broad irradiation that destroys healthy tissue.
My research directly addresses this critical gap. For Head and Neck Squamous Cell Carcinomas (HNSCC), I developed a framework using mixture Hidden Markov Models (HMMs) based on multi-centric data from over 1,200 patients. This model predicts the risk of occult nodal disease-microscopic lymphatic spread that traditional scans completely miss. By accurately predicting this, we can offer targeted, highly personalized radiation therapy, sparing the patient from debilitating side effects.
Similarly, for brain tumors, I developed a dynamic computational framework using Non-Rigid Registration (NRR). During neurosurgery, the brain physically shifts. Our real-time volumetric alignment system updates intra-operative images in sub-seconds, allowing surgeons to achieve complete, safe tumor excisions. It fundamentally removes the surgical “blind spots.”
TheCconnects: With the rapid rise of AI and digital health, what do you see as the biggest challenge for healthcare brands, hospitals, and tech developers in the digital space today?
Dr. Latha Kiran Krishna Rajendran: The single biggest challenge is the ethical, legal, and trust-based integration of predictive intelligence. I recently published a doctrinal analysis exploring strict liability versus fault-based regimes for AI-caused harm.
If an AI-driven clinical decision support tool makes an error, who is responsible? The software developer, the hospital, or the attending physician? Healthcare brands and digital platforms face a massive hurdle in building AI that is not only highly accurate but also completely interpretable and legally compliant. Furthermore, ensuring absolute data privacy while feeding massive multi-omics datasets into these algorithms remains a critical bottleneck. In digital healthcare, trust is the hardest currency to earn and the easiest to lose.
TheCconnects: Looking back at your incredible journey from frontline public health to precision oncology, what key lessons have you learned from your professional career?
Dr. Latha Kiran Krishna Rajendran: I have learned that clinical volume and medical precision are not mutually exclusive; they are two sides of the same coin. Treating 10,000 patients a year has taught me that we desperately need technology to scale high-quality care. A physician’s deep empathy combined with an algorithm’s predictive power is the ultimate medical tool. I’ve also learned that research must be translational to matter. If a brilliant AI model never leaves the laboratory to actually help a patient in a clinic or an OR, it hasn’t fulfilled its purpose.
TheCconnects: Between consulting dozens of patients at Elova Hospitals, peer-reviewing for international conferences, and designing AI-responsive nanocarriers, what do you do in your free time?
Dr. Latha Kiran Krishna Rajendran: Free time is a rare luxury, but I protect it fiercely and dedicate it to continuous learning and academic contribution. I have authored five books on specialized topics like Immunotherapy and Theranostics, which is a deeply fulfilling creative outlet for me. I also actively serve as a peer reviewer for Q1 journals and chair sessions at international data analytics conferences. When I need to completely unplug, I focus on personal wellness and spending quiet, uninterrupted time with my loved ones to recharge my empathy and energy.
TheCconnects: Finally, what advice do you have for aspiring physician-scientists, innovators, or health-tech entrepreneurs entering this rapidly evolving industry?
Dr. Latha Kiran Krishna Rajendran: Do not let the traditional boundaries of your degree confine your impact. If you are a doctor, learn about data analytics. If you are an engineer, deeply understand clinical workflows. The most groundbreaking innovations in history have happened at the intersections of completely different fields.
Most importantly, build solutions that are radically patient-centric. It is very easy to get lost in the excitement of deep learning and big data, but you must constantly ask yourself: How does this improve the patient’s life today? Seamlessly integrate technology and intelligence, but never, ever lose your human empathy. That is what will define true healthcare leadership in the decades to come.
TheCconnects: Dr. Latha Kiran, thank you so much for your time and for sharing your profound, visionary insights with us today. Your work is truly redefining the future of precision medicine and public health.
Dr. Latha Kiran Krishna Rajendran: Thank you, the pleasure was entirely mine. I appreciate the opportunity to share my vision with your readers.
